TABLE 6

Factors associated with time to starting treatment (from presentation to secondary care)

Crude HR (95% CI)Age-adjusted HR (95% CI)Fully adjusted HR (95% CI)#
Age0.98 (0.98–0.99)0.98 (0.98–0.99)
Sex (male versus female)1.17 (1.01–1.35)1.19 (1.01–1.38)1.09 (0.94–1.29)
Ethnic group
 Indian1.03 (0.84–1.26)
 Pakistani0.75 (0.49–1.17)
 Afghani0.24 (0.19–0.29)
 White0.90 (0.63–1.28)
 Bangladeshi1.16 (0.61–2.21)
 Black0.94 (0.71–1.24)
 Chinese0.89 (0.49–1.64)
UK born0.96 (0.71–1.31)1.00 (0.72–1.40)
Sputum smear1.09 (1.01–1.18)1.10 (1.01–1.20)1.09 (0.90–1.32)
TB sensitivity1.27 (1.11–1.44)0.84 (0.70–1.01)
HIV1.03 (0.74–1.43)
Diabetes1.36 (1.13–1.64)1.14 (0.92–1.40)
Hypertension1.55 (1.29–1.87)1.33 (1.06–1.67)0.86 (0.65–1.12)
Renal failure1.28 (1.13–1.46)1.16 (0.99–1.35)
Cancer1.54 (1.20–1.97)1.23 (0.90–1.69)
Lung disease
 Asthma/COPD0.83 (0.29–2.37)
 Bronchiectasis3.16 (0.99–10.1)
 ILD1.27 (0.39–4.19)
 PE1.22 (3.91–3.78)
 Sarcoid1.10 (0.42–2.90)
PTB versus EPTB0.74 (0.64–0.86)0.70 (0.60–0.82)1.10 (0.90–1.34)
Cough1.22 (1.06–1.40)1.22 (1.06–1.41)0.97 (0.81–1.15)
Sweats1.38 (1.18–1.61)1.33 (1.12–1.56)1.24 (1.02–1.51)
Weight loss1.24 (1.08–1.43)1.25 (1.08–1.44)1.03 (0.87–1.22)

HR: hazard ratio; TB: tuberculosis; COPD: chronic obstructive pulmonary disease; ILD: interstitial lung disease; PE: pulmonary embolism; PTB: pulmonary tuberculosis; EPTB: extrapulmonary tuberculosis. #: adjusted for age, sex, sputum smear, hypertension, PTB versus EPTB, cough, sweats and weight loss